Is 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid? Is 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid safe for nursing mother and child? Does 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid extracts into breast milk? Does 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid has any long term or short term side effects on infants? Can 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid influence milk supply or can 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid decrease milk supply in lactating mothers?

There are no reports of infants breastfed during maternal therapy with 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid. Because absorption from the eye is limited, 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

Relevant published information on 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid was not found as of the revision date. In one telephone follow-up study, mothers reported irritability and colicky symptoms in 10% of infants exposed to various antihistamines and drowsiness was reported in 1.6% of infants. None of the reactions required medical attention.[1]

Antihistamines in relatively high doses given by injection can decrease basal serum prolactin in nonlactating women and in early postpartum women.[2][3] However, suckling-induced prolactin secretion is not affected by antihistamine pretreatment of postpartum mothers.[2] The prolactin level in a mother with established lactation may not affect her ability to breastfeed. Low ophthalmic doses of 4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid are unlikely to have the same effect on serum prolactin.